Shell-vial culture and pp65 antigenemia assay in the detection of cytomegalovirus in the first blood sample of renal transplant recipients

Journal of Medical Virology

Volumn 55, Issue 3, 1998, Pages 240-242

  Reina, Jordi ^a   Fernandez Baca, Victoria ^a   Saurina, Juan ^a   Blanco, Isabel ^a   Munar, Maria ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Antigenemia pp65; Cytomegalovirus; Renal transplant recipients; Shell vial culture

Indexed keywords

ANTIGEN DETECTION; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; VIREMIA; VIRUS DETECTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; CULTURE MEDIA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KIDNEY TRANSPLANTATION; PHOSPHOPROTEINS; PROSPECTIVE STUDIES; VIRAL MATRIX PROTEINS; VIREMIA;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; SPRING VIREMIA OF CARP VIRUS;

EID: 0031812322     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199807)55:3<240::AID-JMV10>3.0.CO;2-K     Document Type: Article

References (12)

1. Buller RS, Bailey TC, Ettinger NA, Keener NA, Langlois T, Miller JP, Storch GA (1992): Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients. Journal of Clinical Microbiology 30:2620-2624.
2. Erice A, Holm MA, Hill PC, Henry S, Dirksen CL, Dunn DL, Hillam RP, Balfour HH, Jr (1992): Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. Journal of Clinical Microbiology 30:2822-2825.
3. Gerna G, Revello MG, Percivalle E, Morini F (1992): Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology 30:1232-1237.
4. Landry ML, Ferguson D (1993): Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. Journal of Clinical Microbiology 31:2851-2856.
5. Martin M (1995): Prophylactic cytomegalovirus management strategies. Transplantation Proceedings 27(Suppl.1):S23-S27.
6. Reina J, Blanco I, Munar M (1996): Correlation between human cytomegalovirus quantitative p72 antigenemia and viremia. Clinical Diagnosis and Virology 7:63-67.
7. Rubin RH (1988): Infection in the renal and liver transplant patient. In Rubin RH, Young LS (eds): "Clinical Approach to Infection in the Compromised Host, 2nd ed." New York: Plenum Publishing, pp 557-621.
8. Rubin RH (1990): Impact of cytomegalovirus infection on organ transplant recipients. Review of Infectious Diseases 12:8754-8766.
9. The TH, Van der Ploeg M, Van den Berg AP, Vlieger AM, Van der Giessen M, Van Son WJ (1992): Direct detection of cytomegalovirus in peripheral blood leukocytes. A review of the antigenemia assay and polymerase chain reaction. Transplantation 54:193-198.
10. Van den Berg AP, Van der Bij W, Van Son WJ, Anema J, Van der Giessen M, Schrim J, Tegzess AM, The TH (1989): Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation. A report of 130 consecutive patients. Transplantation 48:991-995.
11. Van der Bij W, Schrim J, Torensma R, Van Son WJ, Tegzess AM, The TH (1988): Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. Journal of Clinical Microbiology 26:2531-2535.
12. Wunderli W, Auracher JD, Zbinden R (1991): Cytomegalovirus detection in transplant recipients: Comparison of different methods in a prospective study. Journal of Clinical Microbiology 29:2648-2650.